Publications
5674 Results
- Journal / Conference
- Journal of Clinical Oncology 27:15s, abst.#5009
- Year
- 2009
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S9921
Southwest Oncology Group S9921: prolonged event free survival in high risk prostate cancer (PC) patients receiving adjuvant androgen deprivation.
- Journal / Conference
- American Society for Preventive Oncology, poster presentation;
- Year
- 2009
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S0000
Communicating the early end of intervention to participants in a large ongoing study
- Journal / Conference
- Blood 113(18):4163-4170
- Year
- 2009
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-9003
International prognostic scoring system for Waldenstrom's macroglobulinemia [PMID19196866]
- Journal / Conference
- Oncology 77(6):395-399
- Year
- 2009
- Research Committee(s)
- Gynecologic
- Study Number(s)
- S0009
Chemotherapy resistance as a predictor of progression-free survival in ovarian cancer patients treated with neoadjuvant chemotherapy and surgical cytoreduction followed by intraperitoneal chemotherapy: a Southwest Oncology Group Study [PMC2837883;PMID20130422]
- Journal / Conference
- Clinical Cancer Research, 15(16):5258-66, 2009;
- Year
- 2009
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-8897
Nitric oxide synthase (N0S3) variants and breast cancer survival in a cooperative group trial (SWOG S8897) [PMC2745926; PMID19671875]
- Journal / Conference
- Gyecologic Oncology 114(2):206-209
- Year
- 2009
- Research Committee(s)
- Gynecologic
- Study Number(s)
- S9912
Southwest Oncology Group trial S9912: intraperitoneal cisplatin and paclitaxel plus intravenous paclitaxel and pegylated liposomal doxorubicin as primary chemotherapy of small-volume residual stage III ovarian cancer [PMC2703693; PMID19464730]
- Journal / Conference
- Clinical Cancer Research 15(18):5663-5770
- Year
- 2009
- Research Committee(s)
- Gastrointestinal, Genitourinary, and Multiple sites
- Study Number(s)
- SWOG-8794, SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)
Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): research objectives workshop 2008 [PMID19723641; PMC2978526]
- Journal / Conference
- Journal of Clinical Oncology 27(21)3540-3546
- Year
- 2009
- Research Committee(s)
- Lung
- Study Number(s)
- S0003
Japan-USA common arm analysis of paclitaxel-carboplatin in advanced non-small cell lung cancer: a model for assessing population-related pharmacogenomics [PMC2717760; PMID19470925]
- Journal / Conference
- Journal of Thoracic Oncology 4(9)suppl 1, abst. PD8.2.6,S522, 2009 (IASLC 13th World Conf on Lung Cancer, poster)
- Year
- 2009
- Research Committee(s)
- Lung
- Study Number(s)
- S0220
Docetaxel is not feasible as consolidation therapy after cisplatin/etoposide/concurrent radiotherapy followed by surgical resection for pancoast tumors: preliminary results of SWOG 0220
- Journal / Conference
- Journal of Thoracic Oncology 4(9);suppl 1, abst. #B2.7, S326;
- Year
- 2009
- Research Committee(s)
- Lung
- Study Number(s)
- S0003, SWOG-9308, S9806